Abstract:Abnormal inflammations are central therapeutic targets in numerous infectious and autoimmune diseases. Dendritic cells (DCs) are involved in these inflammations, serving as both antigen presenters and proinflammatory cytokine providers. As an immuno-suppressor applied to the therapies of multiple sclerosis and allograft transplantation, fingolimod (FTY720) was shown to affect DC migration and its crosstalk with T cells. We posit FTY720 can induce an anergy-polarized phenotype switch on DCs in vitro, especially upon endotoxic activation. A lipopolysaccharide (LPS)-induced mouse bone marrow-derived dendritic cell (BMDC) activation model was employed to test FTY720-induced phenotypic changes on immature and mature DCs. Specifically, methods for morphology, nanostructure, cytokine production, phagocytosis, endocytosis and specific antigen presentation studies were used. FTY720 induced significant alterations of surface markers, as well as decline of shape indices, cell volume, surface roughness in LPS-activated mature BMDCs. These phenotypic, morphological and topographical changes were accompanied by FTY720-mediated down-regulation of proinflammatory cytokines, including IL-6, TNF-alpha, IL-12 and MCP-1. Together with suppressed nitric oxide (NO) production and CCR7 transcription in FTY720-treated BMDCs with or without LPS activation, an inhibitory mechanism of NO and cytokine reciprocal activation was suggested. This implication was supported by the impaired phagocytotic, endocytotic and specific antigen presentation abilities observed in the FTY720-treated BMDCs. In conclusion, we demonstrated FTY720 can induce anergy-polarization in both immature and LPS-activated mature BMDCs. A possible mechanism is FTY720-mediated reciprocal suppression on the intrinsic activation pathway and cytokine production with endpoint exhibitions on phagocytosis, endocytosis, antigen presentation as well as cellular morphology and topography.

Chaeoglobosin Fex Inhibits Poly(i:C)-Induced Activation of Bone Marrow-Derived Dendritic Cells.

Chaetoglobosin F, a small molecule compound, possesses immunomodulatory properties on bone marrow-derived dendritic cells via TLR9 signaling pathway

Chaetoglobosin Fex From The Marine-Derived Endophytic Fungus Inhibits Induction Of Inflammatory Mediators Via Toll-Like Receptor 4 Signaling In Macrophages

Soluble Jagged 1/fc Chimera Protein Induces the Differentiation and Maturation of Bone Marrow-Derived Dendritic Cells

Effects of Crude Extract of Capparis Spinosa L. Fruit Alkaloids on the Maturation of Murine Dendritic Cells

FC-98 Regulates TLR9-Mediated of CXCL-10 Expression in Dendritic Cells Via MAPK and STAT1 Signaling Pathway

CCDC134 Ameliorated Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells

HMOC, a chrysin derivative, induces tolerogenic properties in lipopolysaccharide-stimulated dendritic cells

hIgDFc-Ig inhibits B cell function by regulating the BCR-Syk-Btk-NF-κB signalling pathway in mice with collagen-induced arthritis

Therapeutic Potential Of Ifn-Gamma-Modified Dendritic Cells In Acute And Chronic Experimental Allergic Encephalomyelitis

Anti-inflammatory and Antioxidant Effects of Chaetoglobosin Vb in LPS-induced RAW264.7 Cells: Achieved Via the MAPK and NF-κB Signaling Pathways.

Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways.

Topographical And Biological Evidence Revealed Fty720-Mediated Anergy-Polarization Of Mouse Bone Marrow-Derived Dendritic Cells In Vitro

Regulatory Dendritic Cells Induced by K313 Display Anti-Inflammatory Properties and Ameliorate Experimental Autoimmune Encephalitis in Mice

Effects Of A Novel Tylophorine Analog On Collagen-Induced Arthritis Through Inhibition Of The Innate Immune Response

The Influence of Anti-inflammatory Agents upon the Phenotype and Proinflammatory Cytokine Secretion of Cultured Human Dendritic Cells

Sinomenine inhibits maturation of monocyte-derived dendritic cells through blocking activation of NF-kappa B.

Isorhamnetin, the active constituent of a Chinese herb Hippophae rhamnoides L, is a potent suppressor of dendritic-cell maturation and trafficking

Effects of Cyclosporine A on Murine Bone Marrow-Derived Dendritic Cells

Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway.

Chrysin Suppresses Human CD14(+) Monocyte-Derived Dendritic Cells and Ameliorates Experimental Autoimmune Encephalomyelitis.